Marlboro maker Philip Morris wants to buy COPD drug company Vectura as it looks to find new revenue


In July, Philip Morris Worldwide snapped up the Danish agency Fertin Pharma, which makes medicinal chewing gum. That was adopted by U.S. drug firm OtiTopic, which is growing an aerosolized drug to deal with coronary heart assaults. Philip Morris additionally lately unveiled plans to pay $1.4 billion for the British drug agency Vectura, a significant developer of inhaled therapies for COPD and different respiratory illnesses, together with a possible covid-19 remedy. | Marlboro maker Philip Morris desires to purchase COPD drug firm Vectura because it seems to be to search out new income


Inter Reviewed is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – The content will be deleted within 24 hours.

Related Articles

Back to top button